Revenue - InnoCare Pharma Ltd (SSE:688428) - Alpha Spread

InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 11.33 CNY -2.16% Market Closed
Market Cap: 9.6B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

InnoCare Pharma Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InnoCare Pharma Ltd
Revenue Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
InnoCare Pharma Ltd
SSE:688428
Revenue
ÂĄ625.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Revenue
ÂĄ17.4B
CAGR 3-Years
102%
CAGR 5-Years
68%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Revenue
ÂĄ6.2B
CAGR 3-Years
17%
CAGR 5-Years
266%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Revenue
ÂĄ4.5B
CAGR 3-Years
N/A
CAGR 5-Years
337%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Revenue
ÂĄ5.5B
CAGR 3-Years
33%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Revenue
ÂĄ46.7B
CAGR 3-Years
30%
CAGR 5-Years
42%
CAGR 10-Years
51%

See Also

What is InnoCare Pharma Ltd's Revenue?
Revenue
625.4m CNY

Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Revenue amounts to 625.4m CNY.

What is InnoCare Pharma Ltd's Revenue growth rate?
Revenue CAGR 1Y
-40%

Over the last year, the Revenue growth was -40%.

Back to Top